|
|
|
|
|
|
| |
|
Newsletter Sponsor
|
|
Inhaled drug products for nasal or pulmonary delivery
The prevalence of respiratory diseases around the globe has increased the need for inhaled drug products. Additionally, the lung’s absorptive capacity continues to be explored as an attractive delivery point for both local and systemic applications. Particle engineering, a core strength of Lonza, is critical in achieving the particle size distribution required for effective drug delivery using dry powder inhaler (DPI) devices.
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
